Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,906Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Emgality/Rayvow

PharmaCompass

01

Brand Name : Emgality/Rayvow

Galcanezumab, Lasmiditan

arrow
CPHI Shenzhen
Not Confirmed

Brand Name : Emgality/Rayvow

arrow
CPHI Shenzhen
Not Confirmed

Galcanezumab, Lasmiditan

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 107

2023 Revenue in Millions : 0

Growth (%) : NA

blank